Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,824,090
-
Share change
-
+170,906
-
Total reported value
-
$1,013,374
-
Put/Call ratio
-
72%
-
Price per share
-
$0.36
-
Number of holders
-
27
-
Value change
-
+$60,622
-
Number of buys
-
12
-
Number of sells
-
6
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2023
As of 30 Sep 2023,
IGC Pharma, Inc. - COM NEW (IGC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,824,090 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, DEARBORN PARTNERS LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, Virtu Financial LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.